关注
Alec Griffith
Alec Griffith
在 ohsu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
AT cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia
D Gadi, A Griffith, S Tyekucheva, Z Wang, V Rai, A Vartanov, E Thrash, ...
Leukemia 36 (3), 723-732, 2022
132022
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models
MS Koch, M Zdioruk, MO Nowicki, AM Griffith, E Aguilar, LK Aguilar, ...
Journal for Immunotherapy of Cancer 10 (1), 2022
122022
Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma
MS Koch, M Zdioruk, MO Nowicki, AM Griffith, E Aguilar-Cordova, ...
Molecular Therapy-Oncolytics 26, 275-288, 2022
82022
Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia
D Gadi, A Griffith, Z Wang, S Tyekucheva, V Rai, SM Fernandes, ...
British journal of haematology 197 (2), 207-211, 2022
82022
Mesenchymal Stromal Cells Facilitate Neutrophil-Trained Immunity by Reprogramming Hematopoietic Stem Cells
J Ng, AE Marneth, A Griffith, D Younger, S Ghanta, A Jiao, G Willis, J Han, ...
Journal of Innate Immunity 15 (1), 765-781, 2023
72023
Neutrophil heterogeneity and emergence of a distinct population of CD11b/CD18-activated low-density neutrophils after trauma
IG Riça, BA Joughin, ME Teke, TR Emmons, AM Griffith, LA Cahill, ...
Journal of Trauma and Acute Care Surgery 94 (2), 187-196, 2023
62023
Imbalance in T cell subsets triggers the autoimmune toxicity of PI3K inhibitors in CLL
D Gadi, S Kasar, A Griffith, PY Chiu, S Tyekucheva, V Rai, AR Vartanov, ...
Blood 134, 1745, 2019
62019
Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease
A Sohail, J Hacker, T Ryan, A McGill, R Bergmark, N Bhattacharyya, ...
Journal of Allergy and Clinical Immunology 153 (2), 527-532, 2024
42024
Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis
J Inamo, J Keegan, A Griffith, T Ghosh, A Horisberger, K Howard, ...
bioRxiv, 2023.07. 03.547507, 2023
42023
Distinct injury responsive regulatory T cells identified by multi-dimensional phenotyping
F Guo, B Hancock, A Griffith, H Lin, K Howard, J Keegan, F Zhang, ...
Frontiers in Immunology 13, 833100, 2022
32022
High-dimensional immunophenotyping reveals immune cell aberrations in patients with undiagnosed inflammatory and autoimmune diseases
AA Mueller, T Sasaki, JW Keegan, JP Nguyen, A Griffith, AM Horisberger, ...
The Journal of Clinical Investigation 133 (24), 2023
22023
Cytomegalovirus durably primes neutrophil oxidative burst
TF Marandu, M Dombek, M Gutknecht, M Griessl, IG Riça, B Vlková, ...
Journal of Leukocyte Biology 114 (5), 459-474, 2023
22023
Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis
A Horisberger, A Griffith, J Keegan, A Arazi, J Pulford, E Murzin, K Howard, ...
bioRxiv, 2024.01. 14.575609, 2024
12024
1012 Deep peripheral blood immunophenotyping identifies a subgroup of lupus nephritis patients characterized by high type 1 interferon signaling, persistent activated immune …
A Horisberger, A Griffith, A Arazi, J Keegan, K Howard, T Sasaki, T Ghosh, ...
Lupus Science & Medicine 11 (Suppl 2), 2024
2024
OP0186 DISTINCT PERIPHERAL IMMUNOPHENOTYPING UNDERLINES HISTOPATHOLOGICAL FEATURES IN PATIENTS WITH LUPUS NEPHRITIS IN A LARGE MULTI-CENTER COHORT
A Horisberger, A Griffith, J Keegan, K Howard, J Pulford, E Murzin, ...
Annals of the Rheumatic Diseases 82 (Suppl 1), 122-123, 2023
2023
Dexamethasone blunts the efficacy of locally administered immunostimulatory gene therapy in murine glioblastoma
M Koch, M Zdioruk, M Nowicki, A Griffith, E Aguilar-Cordova, L Aguilar, ...
ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 3), 49-49, 2022
2022
High-Dimensional Immunophenotyping with Mass Cytometry Reveals Unique Immune Cell Aberrations in Patients with Undiagnosed Inflammatory and Autoimmune Diseases
A Mueller, T Sasaki, J Keegan, J Nguyen, A Griffith, E Feig, A Horisberger, ...
ARTHRITIS & RHEUMATOLOGY 74, 1140-1142, 2022
2022
T CELL RECEPTOR (TCR) REPERTORIE AND MOLECULAR PROFILES OF INJURY-RESPONSIVE REGULATORY T CELLS (TREGS)
F Guo, F Zhang, J Keegan, L Cohill, A Griffith, J Ng, K Howard, JA Lederer
SHOCK 53, 120-120, 2020
2020
Increased regulatory T cells suppress traumatic injury induced inflammation and control adaptive immune cell expansion in an experimental model of burn trauma
L Cahill, F Guo, F Zhang, J Ng, A Griffith, K Howard, J Keegan, J Lederer
The Journal of Immunology 204 (1_Supplement), 228.5-228.5, 2020
2020
TOLL-LIKE RECEPTOR 9 (TLR9) PLAYS AN ESSENTIAL ROLE IN INJURY-INDUCED TREG ACTIVATION
F Guo, F Zhang, LA Cahill, JW Keegan, JP Nguyen, AM Griffith, J Ng, ...
SHOCK 51 (6), 101-101, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20